Core outcome set for stable angina pectoris in traditional Chinese medicine (COS-SAP-TCM)

Abstract

Objective: This study aimed to develop a core outcome set (COS) for use in future studies of stable angina pectoris (SAP) in traditional Chinese medicine (TCM).
Methods: Systematic literature reviews and qualitative interviews with cardiologists and patients with SAP treated using TCM were conducted to generate a set of outcomes. Outcomes were prioritized by stakeholders via two rounds of an online Delphi survey and face-to-face consensus meetings. Following the final consensus meeting, a final COS was generated.
Results: An initial set of 324 outcomes was identified. A preliminary list of 65 outcomes was employed in the Delphi study. In total, 223 participants from seven stakeholder groups were invited to score outcomes in the first Delphi round: 87 completed round 1 and 47 completed round 2. Thirty-one participants attended the consensus meeting and agreed on a final core set of outcomes comprising six items across four domains: frequency of angina attack, duration of angina attack, Seattle angina questionnaire, total exercise duration in the exercise treadmill test, cardiovascular events, and QT interval on electrocardiography.
Conclusions: The COS developed in this study provides the minimum requirements for measurement and reporting in future TCM clinical trials for the treatment of SAP. The employment of this COS may reduce heterogeneity across trials and facilitate evidence-based decision-making for stakeholders.

Keywords

Core outcome set / Outcome measure / Stable angina pectoris / Traditional Chinese medicine

References

[[1]] Montalescot G, Sechtem U, Achenbach S, et al.2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.Eur Heart J 2013;34:2949-3003.

[[2]] Opie LH.Angina pectoris: the evolution of concepts.J Cardiovasc Pharmacol Ther 2004;9(Suppl 1):S3-9.

[[3]] Fraker TD, Fihn SD, Gibbons RJ, et al.2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.Circulation 2007;116(23):2762-2772.

[[4]] Fihn SD, Garlin JM, Abrams J, et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation 2012;126(25):3097-3137.

[[5]] Fihn SD, Blankenship JC, Alexander KP, et al.2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.J Am Coll Cardiol 2014;64(18):1929-1949.

[[6]] Mancini GB, Gosselin G, Chow B, et al.Canadian cardiovascular society guidelines for the diagnosis and management of stable ischemic heart disease.Can J Cardiol 2014;30(8):837-849.

[[7]] Valgimigli M, Biscaglia S.Stable angina pectoris.Current Atherosclerosis Reports 2014;16(7):422.

[[8]] Thadani U.Management of patients with chronic stable angina at low risk for serious cardiac events.Am J Cardiol 1997;79(12):24-30.

[[9]] Thadani U.Management of stable angina - current guidelines: a critical appraisal.Cardiovasc Drugs Ther 2016;30(4):419-426.

[[10]] Ambrosio G, Mugelli A, Lopez-Sendón J, et al.Management of stable angina: a commentary on the European Society of Cardiology guidelines.Eur J Prev Cardiol 2016;23(13):1401-1412.

[[11]] Sun MY, Miao Y, Jin M, et al.Effect and safety of guanxinning tablet for stable angina pectoris patients with Xin (Heart)-blood stagnation syndrome: a randomized, multicenter, placebo-controlled trial.Chin J Integr Med 2019;25(9):684-690.

[[12]] Bi YF, Mao JY, Wang XL, et al.Study on syndrome differentiation and treatment in the management of chronic stable coronary artery disease to improve quality of life.Medicine 2018;97(36):e12097.

[[13]] Zhang ZF, Xu FQ, Liu HX, et al.A multicenter, randomized, double-blind clinical study on Wufuxinnaoqing Soft Capsule in treatment of chronic stable angina patients with blood stasis syndrome.Chin J Integr Med 2015;21(8):571-578.

[[14]] Wang Y, Zhang Y, Du Y, et al.A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.Medicine 2019;98(44):e17753.

[[15]] Yi G, Qiu Y, Xiao Y, et al.The usefulness of xuefu zhuyu tang for patients with angina pectoris: a meta-analysis and systematic review.Evidence-based complementary and alternative medicine 2014;2014:521602.

[[16]] Wu J, Yuan DC, Yang MQ, et al.Sini decoction as an adjuvant therapy for angina pectoris: a systematic review of randomized controlled trials.J Tradit Chin Med 2017;37(1):12-22.

[[17]] Zhang MY, Zhang JH, Zhang BL.Outcome measures of clinical trials of stable angina pectoris treated by traditional Chinese medicine in 2015: literature research.Chin J Integr Tradit West Med 2018;38(2):191-197.

[[18]] Zhang L, Zhang J, Chen J, et al.Clinical research of traditional Chinese medicine needs to develop its own system of core outcome sets.Evid Based Complementary Altern Med 2013;2013:202703.

[[19]] Chan AW, Song F, Vickers A, et al.Increasing value and reducing waste: addressing inaccessible research.Lancet 2014;383(9913):257-266.

[[20]] Williamson PR, Altman DG, Blazeby JM, et al.Developing core outcome sets for clinical trials: issues to consider.Trials 2012;13(1):1-8.

[[21]] Kirkham JJ, Davis K, Altman DG, et al.Core Outcome Set-STAndards for Development: The COS-STAD recommendations.PLoS Med 2017;14(11):e1002447.

[[22]] Kirkham JJ, Gorst S, Altman DG, et al.Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.Trials 2019;20(1):1-7.

[[23]] Williamson PR, Altman DG, Bagley H, et al.The COMET handbook: version 1.0.Trials 2017;18(3):1-50.

[[24]] Brookes ST, Macefield RC, Williamson PR, et al.Three nested randomized controlled trials of peer-only or multiple stakeholder group feedback within Delphi surveys during core outcome and information set development.Trials 2016;17(1):1-14.

RIGHTS & PERMISSIONS

2021 Acupuncture and Herbal Medicine